Accordingly, we found that Trpa1-/- CD8+ T cells were more effective in killing tumor cells in vitro and in vivo, which highlights the importance of these immunometabolic modulatory changes exerted to immune cell function. This evidence concerns the gene TRPA1 and neoplasm.